MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
Ekso Bionics Holdings Depreciation & Amortization 2011-2026 | EKSO
Annual Depreciation & Amortization Ekso Bionics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.57 M | 1.61 M | 1.7 M | 887 K | 1.02 M | 620 K | 690 K | 1.01 M | 1.2 M | 1.86 M | 933 K | 745 K | 469 K | 342 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.86 M | 342 K | 1.05 M |
Quarterly Depreciation & Amortization Ekso Bionics Holdings
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 454 K | - | - | 378 K | - | - | - | 406 K | - | - | - | 414 K | - | 632 K | - | 231 K | - | 782 K | - | 1 K | - | 465 K | 23 K | 13 K | - | 56 K | 55 K | 29 K | - | 119 K | 84 K | 43 K | - | 1.31 M | 866 K | 445 K | - | 1.38 M | 908 K | 440 K | - | 653 K | 419 K | 200 K | - | 535 K | 333 K | 157 K | - | 342 K | 227 K | 112 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.38 M | 1 K | 391 K |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
377 M | $ 67.34 | 8.58 % | $ 13.4 B | USA |
 |
Glaukos Corporation
GKOS
|
38.1 M | $ 125.0 | 2.72 % | $ 7.15 B | USA |
 |
Intuitive Surgical
ISRG
|
600 M | $ 422.06 | 0.77 % | $ 151 B | USA |
 |
ICU Medical
ICUI
|
201 M | $ 136.61 | 1.25 % | $ 3.37 B | USA |
 |
iRhythm Technologies
IRTC
|
20.7 M | $ 108.11 | 0.7 % | $ 3.46 B | USA |
 |
Repro Med Systems
KRMD
|
810 K | $ 3.93 | -5.07 % | $ 182 M | USA |
 |
LeMaitre Vascular
LMAT
|
10.4 M | $ 94.48 | 0.98 % | $ 2.14 B | USA |
 |
Masimo Corporation
MASI
|
103 M | $ 178.82 | -0.04 % | $ 9.53 B | USA |
 |
Microbot Medical
MBOT
|
47 K | $ 1.84 | -6.12 % | $ 84.3 M |  Israel |
 |
Milestone Scientific
MLSS
|
78.2 K | $ 0.42 | -4.31 % | $ 34.5 M | USA |
 |
electroCore
ECOR
|
501 K | $ 8.72 | -12.27 % | $ 74 K | USA |
 |
Envista Holdings Corporation
NVST
|
116 M | $ 23.1 | 1.03 % | $ 3.88 B | USA |
 |
Haemonetics Corporation
HAE
|
112 M | $ 71.28 | 2.05 % | $ 3.36 B | USA |
 |
STERIS plc
STE
|
486 M | $ 212.35 | 0.05 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
3.25 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
8.32 M | $ 29.99 | 0.44 % | $ 1.49 B | USA |
 |
InfuSystem Holdings
INFU
|
13.3 M | $ 9.24 | 1.32 % | $ 191 M | USA |
 |
Teleflex Incorporated
TFX
|
178 M | $ 129.84 | -1.72 % | $ 5.79 B | USA |
 |
Utah Medical Products
UTMD
|
826 K | $ 67.65 | -0.5 % | $ 219 M | USA |
 |
Merit Medical Systems
MMSI
|
123 M | $ 64.48 | 2.28 % | $ 3.81 B | USA |
 |
West Pharmaceutical Services
WST
|
171 M | $ 314.5 | -0.89 % | $ 22.7 B | USA |
 |
Pulse Biosciences
PLSE
|
406 K | $ 25.33 | -5.98 % | $ 1.71 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
352 M | $ 10.0 | 1.21 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
7.77 M | $ 0.69 | 3.96 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
1.24 M | $ 65.21 | -2.67 % | $ 214 M | USA |
 |
Predictive Oncology
POAI
|
129 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
2.25 M | $ 26.64 | -1.66 % | $ 1.27 B | USA |
 |
Stereotaxis
STXS
|
626 K | $ 1.78 | -5.07 % | $ 162 M | USA |
 |
Baxter International
BAX
|
981 M | $ 19.38 | 0.16 % | $ 9.94 B | USA |
 |
ResMed
RMD
|
160 M | $ 196.04 | 0.89 % | $ 28.6 B | USA |
 |
AtriCure
ATRC
|
12.1 M | $ 27.1 | -0.62 % | $ 1.29 B | USA |
 |
Harvard Bioscience
HBIO
|
1.74 M | $ 6.2 | -4.4 % | $ 275 M | USA |
 |
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
25.8 M | $ 11.94 | -0.75 % | $ 488 M | USA |
 |
Becton, Dickinson and Company
BDX
|
2.46 B | $ 151.16 | 1.12 % | $ 43.5 B | USA |
 |
Nephros
NEPH
|
140 K | $ 3.42 | -4.74 % | $ 36.3 M | USA |
 |
OraSure Technologies
OSUR
|
10.2 M | $ 4.04 | -3.12 % | $ 297 M | USA |
 |
Repligen Corporation
RGEN
|
78.7 M | $ 122.31 | -3.35 % | $ 6.88 M | USA |